2020 | Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19: A Randomized Clinical Trial | Spinner C.D.; Gottlieb R.L.; Criner G.J.; Arribas López J.R.; Cattelan A.M.; Soriano Viladomiu A.; Ogbuagu O.; Malhotra P.; Mullane K.M.; Castagna A.; Chai L.Y.A.; Roestenberg M.; Tsang O.T.Y.; Bernasconi E.; Le Turnier P.; SHAN-CHWEN CHANG ; Sengupta D.; Hyland R.H.; Osinusi A.O.; Cao H.; Blair C.; Wang H.; Gaggar A.; Brainard D.M.; McPhail M.J.; Bhagani S.; Ahn M.Y.; Sanyal A.J.; Huhn G.; Marty F.M. | JAMA - Journal of the American Medical Association | 872 | 818 | |